3

PRIMARY DOCUMENT

Company: COLLEGIUM PHARMACEUTICAL, INC
Filed: May 24, 2021
Period of Report: May 24, 2021
Accession Number: 0001192482-21-000451

View Document ↗ View on SEC.gov ↗